Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ibα under flow conditions:: specific synergy of receptor-ligand interactions

被引:39
作者
Nishiya, T
Kainoh, M
Murata, M
Handa, M
Ikeda, Y
机构
[1] Keio Univ, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Ctr Blood, Tokyo 1608582, Japan
[3] Toray Industries Ltd, Kanagawa, Japan
关键词
D O I
10.1182/blood.V100.1.136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Liposomes carrying both recombinant glycoprotein Ia/IIa (rGPIa/IIa) and Ibalpha (rGPIbalpha) (rGPIa/IIa-Ibalpha-liposomes) instantaneously and irreversibly adhered to the collagen surface in the presence of soluble von Willebrand factor (VWF) at high shear rates, in marked contrast with translocation of liposomes carrying rGPIbalpha alone on the VWF surface. In the absence of soluble VWF, the adhesion of rGPIa/IIa-Ibalpha-liposomes to the collagen surface decreased with increasing shear rates, similar to liposomes carrying rGPIa/IIa alone. While adhesion of liposomes with exofacial rGPIa/IIa and rGPIbalpha densities of 2.17x10(3) and 1.00x10(4) molecules per particle, respectively, was efficient at high shear rates, reduction in rGPIbalpha. density to 5.27x10(3) molecules per particle resulted in decreased adhesion even in the presence of soluble VWF. A 50% reduction in the exofacial rGPIa/IIa density resulted in a marked decrease in the adhesive ability of the liposomes at all shear rates tested. The inhibitory effect of antibody against GPIbalpha (GUR83-35) on liposome adhesion was greater at higher shear rates. Further, the anti-GPIa antibody (Gi9) inhibited liposome adhesion more than GUR83-35 at all shear rates tested. These results suggest that the rGPIa/IIa-collagen interaction dominates the adhesion of rGPIa/IIa-Ibalpha-liposomes to the collagen surface at low shear rates, while the rGPIa/IIa-collagen and rGPIbalpha-VWF interaction complements each other, and they synergistically provide the needed functional integration required for liposome adhesion at high shear rates. This study thus has confirmed for the first time the proposed mechanisms of platelet adhesion to the collagen surface under flow conditions using the liposome system.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 38 条
[1]   ERYTHROCYTES WITH COVALENTLY BOUND FIBRINOGEN AS A CELLULAR REPLACEMENT FOR THE TREATMENT OF THROMBOCYTOPENIA [J].
AGAM, G ;
LIVNE, AA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (02) :105-112
[2]  
ALEVRIADOU BR, 1993, BLOOD, V81, P1263
[3]   AMINO-ACID-SEQUENCE OF THE HUMAN FIBRONECTIN RECEPTOR [J].
ARGRAVES, WS ;
SUZUKI, S ;
ARAI, H ;
THOMPSON, K ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1183-1190
[4]   Glycoprotein Ib von Willebrand factor interactions activate tyrosine kinases in human platelets [J].
Asazuma, N ;
Ozaki, Y ;
Satoh, K ;
Yatomi, Y ;
Handa, M ;
Fujimura, Y ;
Miura, S ;
Kume, S .
BLOOD, 1997, 90 (12) :4789-4798
[5]   PROTEIN IMMOBILIZATION ON THE SURFACE OF LIPOSOMES VIA CARBODIIMIDE ACTIVATION IN THE PRESENCE OF N-HYDROXYSULFOSUCCINIMIDE [J].
BOGDANOV, AA ;
KLIBANOV, AL ;
TORCHILIN, VP .
FEBS LETTERS, 1988, 231 (02) :381-384
[6]   THROMBOERYTHROCYTES - INVITRO STUDIES OF A POTENTIAL AUTOLOGOUS, SEMIARTIFICIAL ALTERNATIVE TO PLATELET TRANSFUSIONS [J].
COLLER, BS ;
SPRINGER, KT ;
BEER, JH ;
MOHANDAS, N ;
SCUDDER, LE ;
NORTON, KJ ;
WEST, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :546-555
[7]   DISTINCT ABNORMALITIES IN THE INTERACTION OF PURIFIED TYPE-IIA AND TYPE-IIB VONWILLEBRAND-FACTOR WITH THE 2 PLATELET BINDING-SITES, GLYCOPROTEIN COMPLEX-IB-IX AND COMPLEX-IIB-IIIA [J].
DEMARCO, L ;
MAZZUCATO, M ;
DEROIA, D ;
CASONATO, A ;
FEDERICI, AB ;
GIROLAMI, A ;
RUGGERI, ZM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :785-792
[8]   BINDING OF VONWILLEBRAND-FACTOR TO GLYCOPROTEIN-IB AND IIB/IIIA COMPLEX - AFFINITY IS RELATED TO MULTIMERIC SIZE [J].
FEDERICI, AB ;
BADER, R ;
PAGANI, S ;
COLIBRETTI, ML ;
DEMARCO, L ;
MANNUCCI, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) :93-99
[9]   HIGHLY EFFICIENT IMMUNOLIPOSOMES PREPARED WITH A METHOD WHICH IS COMPATIBLE WITH VARIOUS LIPID COMPOSITIONS [J].
HOLMBERG, E ;
MARUYAMA, K ;
LITZINGER, DC ;
WRIGHT, S ;
DAVIS, M ;
KABALKA, GW ;
KENNEL, SJ ;
HUANG, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1272-1278
[10]  
HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8